As soon as the early signs of spring appear, golfers start counting down the days until their first tee-off of the season! Golfing is a great outdoor sport, a good […]

Menopause is associated with a range of symptoms which may affect quality of life as well may increase an individual’s risk of chronic conditions such as osteoporosis or cardiovascular disease.  […]

The National Osteoporosis Foundation and the American Society for Preventive Cardiology formed an expert panel and completed a detailed review of all published research evaluating the effects of calcium intake […]

Strontium ranelate (Protelos) is a drug approved for the treatment of osteoporosis in Europe, but not in Canada. It is effective in reducing fractures . Recently the European Medicines Agency […]

Osteoporosis Canada advises individuals on denosumab therapy to discuss their treatment with their physician prior to delaying therapy, stopping therapy or missing a scheduled dose.   Denosumab (Prolia) has been […]

Romosozumab EVENITY™ (romosozumab injection) Romosozumab, a sclerostin inhibitor, is the first new approach to the treatment of osteoporosis and fracture risk in almost a decade.Romosozumab (EVENITY™) significantly and rapidly (over […]

HOW GOOD IS YOUR BONE HEALTH?   KNOW YOUR RISK. Thank you for completing the Osteoporosis Canada Know Your Risk quiz. One or more of your responses were highlighted as potential risk […]

Osteoporosis Canada together with Arthritis Society Canada presents Osteoporosis and Osteoarthritis: What You Need To Know. Despite the fact that osteoporosis, arthritis and osteoarthritis (a form of arthritis) are completely different […]